Small molecule compound
Product Name
CAS Number
Specification
TP
DMF
Status
Sugammadex Sodium
343306-79-6
In-house
√
Tafluprost
209860-87-7
In-house
√
Tasimelteon
609799-22-6
In-house
√
Tepotinib
1100598-32-0
Q4 2025
Q2 2026
Tezacaftor
1152311-62-0
Q3 2025
Q1 2026
Ticagrelor
274693-27-5
EP, In-house
√
Tofacitinib Citrate
540737-29-9
In-house
√
Tofacitinib Citrate
540737-29-9
In-house
√
Tofogliflozin
1201913-82-7
Q4 2025
Q2 2026
Tovorafenib
1096708-71-2
Q4 2025
Q2 2026
Trametinib dimethyl sulfoxide
1187431-43-1
In-house
Q4 2025
Travoprost
157283-68-6
USP, In-house
√
Tucatinib
937263-43-9
Q3 2025
Q1 2026
Upadacitinib
1310726-60-3
Q3 2025
Q1 2026
Vanzacaftor
2374124-49-7
Q4 2025
Q2 2026
Venetoclax
1257044-40-8
Q3 2025
Q1 2026
Zavegepant
1337918-83-8
Q1 2026
Q3 2026